Charting the Course: Healthcare Priorities in the New Trump Administration
Webinar | 11.22.24, 12:00 PM EST - 1:00 PM EST
Address
Virtual
Join us for an insightful webinar as we explore the health care priorities under the new Congress and Administration following the recent election. Crowell Health Care's Jodi Daniel, former Director in the Office of the National Coordinator for Health IT, and Chris Flynn, co-chair of the firm's Health Care Group, along with our Government Affairs colleagues, Aaron Cummings, former Chief of Staff to U.S. Senator Chuck Grassley (R-IA), Scott Douglas, former Finance Director to Senator Mitch McConnell (R-KY), and Stephen Holland, former Senior Health Counsel to the House Committee on Energy & Commerce and Ranking Member Frank Pallone, Jr. (D-NJ), will provide a comprehensive overview of the anticipated legislative and regulatory changes.
Key topics to be discussed include:
- Digital health/ AI policy
- Healthcare workforce challenges
- Supply chain issues
- Medicare and Medicare Advantage reforms
- Medicaid policy changes
- Future of the Affordable Care Act (ACA)
- Drug pricing and healthcare price transparency
- Legislative actions during the lame duck session
Gain valuable insights from Capitol Hill and federal agencies, and understand the implications of these changes on the healthcare landscape. We look forward to your participation and hope you will join us for this crucial discussion on the future of healthcare policy.
Read more on the US Presidential and 119th Congress Transition Series here.
For more information, please visit these areas: Health Care, Government Affairs
Participants
Insights
Webinar | 07.01.26
Digital Product Passports and Digital Material Passports: What You Need to Know (Part 2)
Digital Product Passports are set to transform how products are sold across Europe. For consumers, this means unprecedented access to product information. Sustainability and compliance data, alongside other key product details, will become far easier to access and compare than ever before. As a “single source of truth” for products, DPPs may also enable EU authorities to identify non-compliance more quickly and efficiently, potentially restricting or preventing non-compliant products from entering the European market.
